Delivery Order SPE2DR25D1022-SPE2DR26FQV5D
- Not listed
- The Defense Logistics Agency awarded a $27,893.36 delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of February 2, 2026. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of January 22, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and...
- The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on January 16, 2026, with completion targeted for February 9, 2026. This is a non-set-aside, competitively awarded contract executed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Benlysta 200 mg/ml auto-injectors. The order, which is a child contract with an ultimate completion date of February 18, 2026, carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,330.68 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units. The contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price procurement executed without set-aside provisions, indicating open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its extensive federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Benlysta 200 mg/ml auto-injectors. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a non-competitive set-aside award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $6,973.34 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication. This competitively awarded, firm fixed-price contract has an ultimate completion date of January 30, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of BENLYSTA 200 MG/ML auto-injector pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 4, 2026, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is a...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQV5DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,946.68 to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of February 19, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical supplier to federal healthcare systems, particularly the Department of Defense and Veterans Affairs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. That comprehensive vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. The parent company, Cencora, Inc., also maintains a separate IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, reflecting the critical role these contractors play in the federal pharmaceutical supply chain for military treatment facilities and other government medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 1/27/26 |